Previous 10 | Next 10 |
2024-02-06 16:20:14 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards Lifesciences Q4 2023 Earnings Preview Edwards stock jumps 8% on FDA appro...
Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...
2024-02-06 01:10:00 ET Summary Some big tech results fizzled, but there were two standouts last week. Nine S&P 500® companies have outlier earnings dates this week - MCD, IEX, EW, MAA, MCK, HSY, COP, TROW, CTLT. 1,558 companies are expected to report during the second...
2024-02-05 17:05:31 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Seeking Alpha’s Quant Rating on Edwards Lifesciences Read the full artic...
2024-02-02 12:20:25 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards gets FDA okay for Evoque tricuspid valve replacement system Edwards Lifes...
2024-02-02 10:51:42 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards Lifesciences provides 2024 outlook, OKs additional $1B stock buyback Edwa...
Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR). The EVOQUE system is indicat...
2024-01-31 15:33:55 ET More on Boston Scientific, Stryker, etc. Boston Scientific Corporation (BSX) Q4 2023 Earnings Call Transcript Stryker Corporation (SYK) Q4 2023 Earnings Call Transcript Boston Scientific: Portfolio Updates Driving Top-Line Growth Boston...
2024-01-31 08:05:00 ET Summary The Ithaka Group is an independent investment boutique that specializes in managing high-quality, concentrated growth equity portfolios. During the fourth quarter Ithaka’s portfolio outperformed in a strong market, rising 18.4% vs the R1G risi...
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2023 after the market closes on Tuesday, February 6, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial ...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the proposed return of capital announced on June 19, 2024 . The Company has prepared and mailed its ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
2024-07-25 16:00:08 ET Pito Chickering from Deutsche Bank issued a price target of $85.00 for EW on 2024-07-25 13:36:00. The adjusted price target was set to $85.00. At the time of the announcement, EW was trading at $60.58. The overall price target consensus is at $109....